Chromone–lipoic acid conjugate: Neuroprotective agent having acceptable butyrylcholinesterase inhibition, antioxidant and copper-chelation activities

PURPOSE: Alzheimer’s disease (AD) is a multifaceted neurodegenerative disease. To target simultaneously multiple pathological processes involved in AD, natural-origin compounds with unique characteristics are promising scaffolds to develop novel multi-target compounds in the treatment of different n...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Daru
Autors principals: Jalili-Baleh, Leili, Nadri, Hamid, Forootanfar, Hamid, Küçükkılınç, Tuba Tüylü, Ayazgök, Beyza, Sharifzadeh, Mohammad, Rahimifard, Mahban, Baeeri, Maryam, Abdollahi, Mohammad, Foroumadi, Alireza, Khoobi, Mehdi
Format: Artigo
Idioma:Inglês
Publicat: Springer International Publishing 2021
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC8149529/
https://ncbi.nlm.nih.gov/pubmed/33420969
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40199-020-00378-1
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars